TrialBMC cardiovascular disorders2025

Innovative nitric oxide delivery technology for postoperative pulmonary hypertension in congenital heart disease patients: a clinical trial.

Ruofan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.